Trace Biosciences
PrivateLast Round
Series A
Aug 12, 2026
Total Funding Raised
$3.99M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Trace Biosciences is a biotechnology company that develops nerve-targeted fluorescent imaging agents designed to improve surgical safety by enabling real-time visualization of nerves.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trace Biosciences Comparables
Compare Trace Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alume Biosciences | 93% | |
| Illuminare Biotechnologies | 87% | |
| Curadel Surgical Innovations, Inc. | 82% |
Trace Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 12, 2026 | ||||
| Grant | Sep 1, 2023 | ||||
| Grant | Jul 1, 2023 | ||||
| Pre Seed | May 17, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
Grant | Nov 1, 2021 |
Trace Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| ONAMI | Pre Seed |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| ARPA-H | Grant |
| SciFounders | Accelerator |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 12, 2026
Raised $8.3M in seed funding.
- May 13, 2026
Monthly visitors increased 45% MoM.
Trace Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Trace Biosciences's valuation, stock price, and market status.
Is Trace Biosciences a public or private company?
Trace Biosciences is a private company.
What is the current stock price of Trace Biosciences?
Trace Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Trace Biosciences worth (valuation)?
Valuation information for Trace Biosciences is not publicly available.
Can I buy Trace Biosciences stock?
Trace Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Trace Biosciences's last funding round?
Trace Biosciences's most recent funding round was Grant on September 1, 2023.
Who are the main investors in Trace Biosciences?
Key investors in Trace Biosciences include National Cancer Institute, ONAMI, National Institute of Neurological Disorders and Stroke (NINDS), ARPA-H, SciFounders.
Will Trace Biosciences IPO soon?
No public IPO plans have been announced for Trace Biosciences.
How can I track Trace Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Trace Biosciences's secondary market activity and sign up for updates.